Bath & Body Works, Inc. (NYSE:BBWI) Shares Acquired by Janus Henderson Group PLC

Janus Henderson Group PLC grew its stake in Bath & Body Works, Inc. (NYSE:BBWI - Free Report) by 15.6% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,296,280 shares of the company's stock after purchasing an additional 174,760 shares during the period. Janus Henderson Group PLC owned about 0.60% of Bath & Body Works worth $50,256,000 at the end of the most recent quarter.

Other hedge funds have also bought and sold shares of the company. SRS Capital Advisors Inc. boosted its position in Bath & Body Works by 99.7% in the 4th quarter. SRS Capital Advisors Inc. now owns 659 shares of the company's stock worth $26,000 after purchasing an additional 329 shares in the last quarter. Golden State Wealth Management LLC purchased a new stake in Bath & Body Works in the 4th quarter worth approximately $26,000. UMB Bank n.a. boosted its position in Bath & Body Works by 58.8% in the 4th quarter. UMB Bank n.a. now owns 905 shares of the company's stock worth $35,000 after purchasing an additional 335 shares in the last quarter. Lindbrook Capital LLC boosted its position in Bath & Body Works by 81.9% in the 4th quarter. Lindbrook Capital LLC now owns 957 shares of the company's stock worth $37,000 after purchasing an additional 431 shares in the last quarter. Finally, Smartleaf Asset Management LLC boosted its position in Bath & Body Works by 135.0% in the 4th quarter. Smartleaf Asset Management LLC now owns 1,013 shares of the company's stock worth $39,000 after purchasing an additional 582 shares in the last quarter. Hedge funds and other institutional investors own 95.14% of the company's stock.

Analyst Upgrades and Downgrades

Several equities research analysts have commented on the company. Telsey Advisory Group restated an "outperform" rating and issued a $43.00 price objective on shares of Bath & Body Works in a research report on Thursday, February 27th. Barclays decreased their target price on Bath & Body Works from $38.00 to $31.00 and set an "equal weight" rating on the stock in a research report on Monday, May 12th. Morgan Stanley decreased their target price on Bath & Body Works from $49.00 to $43.00 and set an "overweight" rating on the stock in a research report on Tuesday, May 6th. Raymond James decreased their target price on Bath & Body Works from $46.00 to $37.00 and set an "outperform" rating on the stock in a research report on Thursday, April 17th. Finally, Cowen reiterated a "buy" rating on shares of Bath & Body Works in a research report on Thursday, February 27th. Four research analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $41.69.

Bath & Body Works Stock Down 0.7%

Shares of BBWI traded down $0.24 during midday trading on Friday, reaching $33.73. The company had a trading volume of 5,679,860 shares, compared to its average volume of 4,843,843. Bath & Body Works, Inc. has a 1-year low of $24.96 and a 1-year high of $52.99. The stock has a market cap of $7.18 billion, a PE ratio of 8.23, a price-to-earnings-growth ratio of 0.92 and a beta of 1.87. The firm has a 50 day simple moving average of $29.97 and a 200-day simple moving average of $33.96.

Bath & Body Works (NYSE:BBWI - Get Free Report) last issued its earnings results on Thursday, February 27th. The company reported $2.09 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.04 by $0.05. Bath & Body Works had a negative return on equity of 44.03% and a net margin of 12.43%. The business had revenue of $2.79 billion during the quarter, compared to the consensus estimate of $2.78 billion. As a group, sell-side analysts anticipate that Bath & Body Works, Inc. will post 3.3 earnings per share for the current fiscal year.

Bath & Body Works Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, June 20th. Investors of record on Friday, June 6th will be given a dividend of $0.20 per share. This represents a $0.80 dividend on an annualized basis and a dividend yield of 2.37%. Bath & Body Works's payout ratio is 21.98%.

Bath & Body Works declared that its Board of Directors has approved a share repurchase plan on Thursday, February 27th that permits the company to buyback $500.00 million in shares. This buyback authorization permits the company to repurchase up to 6.4% of its stock through open market purchases. Stock buyback plans are often a sign that the company's board of directors believes its stock is undervalued.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.